METHOD FOR TREATMENT OF PATIENTS WITH ALLERGIC DISEASES BY AUTOLOGICAL LYMPHOCYTES Russian patent published in 2017 - IPC A61M1/38 

FIELD: medicine.

SUBSTANCE: autologous lymphocytes are introduced. At that, a single venous blood sample is taken from the patient, with lymphocytes separation from the blood, the lymphocytes are first resuspended in a phosphate-saline buffer, and then placed into physiological saline, uniformly mixed and stored in a freezer in test tubes at a concentration of 1-2 million cells in a volume of 0.4 to 0.5 ml. One dose of the obtained lymphocytes is administered to the patient, and the remaining portions are frozen and introduced later, pre-warmed to the body temperature, intradermally paravertebrally at 1-2 points, 2 times a week, for 4-5 weeks.

EFFECT: method allows to reduce the incidence of disease symptoms and to increase the duration of the disease-free period, the method has no side effects, it is completely safe for patients.

9 ex, 8 dwg